XRN Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

38.060

Open

37.600

VWAP

37.67

Vol

79.30K

Mkt Cap

497.10M

Low

37.390

Amount

2.99M

EV/EBITDA(TTM)

24.83

Total Shares

13.23M

1.29B

EV/OCF(TTM)

17.32

P/S(TTM)

3.28

Chiron Real Estate Inc., formerly Global Medical REIT Inc., is an internally managed real estate investment trust (REIT). The Company acquires healthcare facilities leased to physician groups and regional and national healthcare systems. The Company conducts its business through its limited partnership subsidiary, Chiron Real Estate LP (operating partnership). It owns 92.0% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 8.0% of the operating partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the Operating Partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospitals and others. Its portfolio is located in various areas, including Texas, Florida, Ohio, Arizona, Pennsylvania, Illinois, and Others.

Events Timeline

(ET)

2026-06-30

09:30:00

Chiron Real Estate Sells Seven Rehab Facilities for $217M

2026-06-16 (ET)

2026-06-16

17:30:00

Chiron Real Estate Files to Sell 2.33M Shares of Common Stock

2026-05-06 (ET)

2026-05-06

17:00:00

Chiron Reports Q1 Revenue of $38.1M, CEO Emphasizes Growth Investment Strategy

2026-05-06

17:00:00

Chiron Real Estate Acquires Three Senior Housing Communities for $425 Million

News

7.5

06-30seekingalpha

Chiron Real Estate Sells Seven Rehabilitation Facilities

8.5

06-30Newsfilter

Chiron Real Estate Completes Sale of Seven Rehabilitation Facilities

8.5

06-01Newsfilter

Chiron Real Estate Acquires Two Senior Living Communities for Growth

8.5

06-01Yahoo Finance

Chiron Real Estate Acquires Two Senior Living Communities

2.0

05-08NASDAQ.COM

Chiron (XRN) Q1 2026 Earnings Call Transcript

2.0

04-16Newsfilter

Chiron Real Estate Inc. Schedules Q1 2026 Financial Results Release

0 Analyst Rating

Wall Street analysts forecast XRN stock price to rise

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

Alliance Global

Buy

maintain

$40 -> $43

AI Analysis

2026-07-01

Reason

Alliance Global

Price Target

$40 -> $43

AI Analysis

2026-07-01

maintain

Buy

Reason

Alliance Global raised the firm's price target on Chiron Real Estate to $43 from $40 and keeps a Buy rating on the shares after the company announced disposition of seven inpatient rehab facilities, in-line with the company's portfolio transformation strategy.

Raymond James

Market Perform

initiated

$NULL

2026-06-16

Reason

Raymond James

Price Target

$NULL

2026-06-16

initiated

Market Perform

Reason

Raymond James initiated coverage of Chiron Real Estate with a Market Perform rating and no price target. The firm says the company's transition from secondary market outpatient medical to U.S. senior housing operating portfolio will prove dilutive to earnings and near-term value. Chiron's organic upside from its investments will take time and "provide little near-term measuring sticks for performance," the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for XRN

Unlock Now

Valuation Metrics

The current forward P/E ratio for Chiron Real Estate Inc (XRN.N) is 232.56, compared to its 5-year average forward P/E of 191.82. For a more detailed relative valuation and DCF analysis to assess Chiron Real Estate Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

191.82

Current PE

232.56

Overvalued PE

244.48

Undervalued PE

139.16

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

12.97

Current EV/EBITDA

12.57

Overvalued EV/EBITDA

15.06

Undervalued EV/EBITDA

10.88

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

3.96

Current PS

3.52

Overvalued PS

5.33

Undervalued PS

2.59

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

stocks bearish tomorrow sell

Intellectia · 26 candidates

Relative Vol: >= 1.50Moving Average Relationship: PriceBelowMA5, PriceBelowMA20Is Optionable: TrueOne Day Rise Prob: <= 50.00One Day Predict Return: <= 0.0%Macd: bearish

Ticker

Name

Market Cap$

XPOF

Xponential Fitness Inc

320.79M

TNDM

Tandem Diabetes Care Inc

1.27B

TOST

Toast Inc

17.03B

TSSI

TSS Inc

457.15M

IRS

IRSA Inversiones y Representaciones SA

1.13B

TRDA

Entrada Therapeutics Inc

265.53M

Whales Holding XRN

Heartland Advisors, Inc.

Trading Trends

People Also Watch

Frequently Asked Questions

What is Chiron Real Estate Inc (XRN) stock price today?

The current price of XRN is 37.56 USD — it has increased 0.62

What is Chiron Real Estate Inc (XRN)'s business?

What is the price predicton of XRN Stock?

Wall Street analysts forecast XRN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for XRN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.